Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)
NCT ID: NCT00449826
Last Updated: 2012-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
107 participants
INTERVENTIONAL
2006-09-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Recent advancements in technology have enabled CTA to clearly define coronary artery anatomy with great accuracy and to guide treatment strategies in select patient populations. We are investigating that CTA may be used, as an alternative to conventional angiograms, for the risk stratification of patients with high risk NSTE-ACS.
Patients eligible for the study will be high risk NSTE-ACS and awaiting an angiogram. Enrolled patients will undergo CTA prior to the angiogram. With each CTA the patient will be injected with a small dose of an X-ray dye and will be asked to lie still on the "scanning bed" for a period of 5-10 minutes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coronary Computed Tomographic Angiography in Emergency Department Chest Pain Patients at Intermediate Risk of Acute Coronary Syndrome
NCT00473863
Safety and Cost-efficiëncy of New Imaging Techniques in Patients Suspected of Coronary Artery Disease
NCT04939207
Risk Evaluation and Stratification of Low Risk for Cardiovascular Disease in Women
NCT03929341
Coronary CT Angiography for Improved Assessment of Suspected Acute Coronary Syndrome
NCT03129659
Rule Out Myocardial Infarction by Computer Assisted Tomography
NCT00990262
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computed Tomographic Angiography
CT scan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Angina \[accelerating pattern or prolonged episode (\> 20 minutes) or recurrent episode at rest or with minimal effort within preceding 24 hours\]; and (13)
2. Elevated Troponin - T (≥0.1 ug/L) or ECG changes consistent with ischemia \[ST depression ≥ 0.1 mV, transient ST segment elevation ≥ 0.1 mV (\< 20 minutes)\]) (11;13)
* Planned conventional invasive coronary angiography
Exclusion Criteria
* Renal Insufficiency (GFR \< 60 ml/min)
* Allergy to contrast agent
* Refractory angina requiring urgent/emergent coronary angiography (as per treating physician)
* Contraindication to radiation exposure (e.g. pregnancy)
* Uncontrolled HR
* Previous CABG or PCI/Stent
* Atrial fibrillation, frequent atrial or ventricular ectopy (\> 1 / minute)
* Unable to perform 20 second breath-hold
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Heart Institute Research Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin Chow
Dr Benjamin Chow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carole Dennie, MD
Role: STUDY_DIRECTOR
The Ottawa Hospital
Derek So, MD
Role: STUDY_DIRECTOR
Ottawa Heart Institute Research Corporation
Chris Glvoer, MD
Role: STUDY_DIRECTOR
Univeristy of Ottawa Heart Institute
Benjamin JW Chow, MD
Role: PRINCIPAL_INVESTIGATOR
Ottawa Heart Institute Research Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Ottawa Heart Institute
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UOHI 2006361-01H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.